Literature DB >> 25754111

YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.

Namrata Bora-Singhal1, Jonathan Nguyen1, Courtney Schaal1, Deepak Perumal2, Sandeep Singh3, Domenico Coppola4, Srikumar Chellappan1.   

Abstract

Non-small cell lung cancer (NSCLC) is highly correlated with smoking and has very low survival rates. Multiple studies have shown that stem-like cells contribute to the genesis and progression of NSCLC. Our results show that the transcriptional coactivator yes-associated protein 1 (YAP1), which is the oncogenic component of the Hippo signaling pathway, is elevated in the stem-like cells from NSCLC and contributes to their self-renewal and ability to form angiogenic tubules. Inhibition of YAP1 by a small molecule or depletion of YAP1 by siRNAs suppressed self-renewal and vascular mimicry of stem-like cells. These effects of YAP1 were mediated through the embryonic stem cell transcription factor, Sox2. YAP1 could transcriptionally induce Sox2 through a physical interaction with Oct4; Sox2 induction occurred independent of TEAD2 transcription factor, which is the predominant mediator of YAP1 functions. The binding of Oct4 to YAP1 could be detected in cell lines as well as tumor tissues; the interaction was elevated in NSCLC samples compared to normal tissue as seen by proximity ligation assays. YAP1 bound to Oct4 through the WW domain, and a peptide corresponding to this region could disrupt the interaction. Delivery of the WW domain peptide to stem-like cells disrupted the interaction and abrogated Sox2 expression, self-renewal, and vascular mimicry. Depleting YAP1 reduced the expression of multiple epithelial-mesenchymal transition genes and prevented the growth and metastasis of tumor xenografts in mice; overexpression of Sox2 in YAP1 null cells rescued these functions. These results demonstrate a novel regulation of stem-like functions by YAP1, through the modulation of Sox2 expression.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Non-small cell lung cancer; Self-renewal; Side-population cells; Transcriptional regulation; Vascular mimicry

Mesh:

Substances:

Year:  2015        PMID: 25754111      PMCID: PMC4441573          DOI: 10.1002/stem.1993

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  73 in total

1.  Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex.

Authors:  Mizuho Tomioka; Masazumi Nishimoto; Satoru Miyagi; Tomoko Katayanagi; Nobutaka Fukui; Hitoshi Niwa; Masami Muramatsu; Akihiko Okuda
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

2.  Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.

Authors:  Tobias A Beyer; Alexander Weiss; Yuliya Khomchuk; Kui Huang; Abiodun A Ogunjimi; Xaralabos Varelas; Jeffrey L Wrana
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

Review 3.  Transcriptional regulatory mechanisms that govern embryonic stem cell fate.

Authors:  Satyabrata Das; Dana Levasseur
Journal:  Methods Mol Biol       Date:  2013

Review 4.  The multiple roles for Sox2 in stem cell maintenance and tumorigenesis.

Authors:  Kuancan Liu; Baoshun Lin; Meng Zhao; Xiangyue Yang; Min Chen; Anding Gao; Fei Liu; Jianwen Que; Xiaopeng Lan
Journal:  Cell Signal       Date:  2013-02-15       Impact factor: 4.315

5.  Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

Authors:  Stefano Piccolo; Michelangelo Cordenonsi; Sirio Dupont
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

Review 6.  The Hippo signaling pathway and stem cell biology.

Authors:  Azucena Ramos; Fernando D Camargo
Journal:  Trends Cell Biol       Date:  2012-05-31       Impact factor: 20.808

7.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

8.  Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

Authors:  Kuancan Liu; Ming Jiang; Yun Lu; Hao Chen; Jun Sun; Shaoping Wu; Wei-Yao Ku; Hiroshi Nakagawa; Yoshiaki Kita; Shoji Natsugoe; Jeffrey H Peters; Anil Rustgi; Mark W Onaitis; Amy Kiernan; Xiaoxin Chen; Jianwen Que
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

9.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

Authors:  Nailing Zhang; Haibo Bai; Karen K David; Jixin Dong; Yonggang Zheng; Jing Cai; Marco Giovannini; Pentao Liu; Robert A Anders; Duojia Pan
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

10.  βArrestin-1 and Mcl-1 modulate self-renewal growth of cancer stem-like side-population cells in non-small cell lung cancer.

Authors:  Sandeep Singh; Namrata Bora-Singhal; Jodi Kroeger; Hanane Laklai; Srikumar P Chellappan
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more
  65 in total

1.  Induction of cells with prostate cancer stem-like properties from mouse induced pluripotent stem cells via conditioned medium.

Authors:  Naijin Xu; Xiezhao Li; Masami Watanabe; Hideo Ueki; Hao Hu; Na Li; Motoo Araki; Koichiro Wada; Abai Xu; Chunxiao Liu; Yasutomo Nasu; Peng Huang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  SOX5 interacts with YAP1 to drive malignant potential of non-small cell lung cancer cells.

Authors:  Hongbo Zou; Shuang Wang; Songtao Wang; Hong Wu; Jing Yu; Qian Chen; Wei Cui; Ye Yuan; Xianmei Wen; Jian He; Lin Chen; Ruilian Yu; Ming Zhang; Haitao Lan; Guoxiang Jin; Xia Zhang; Xiuwu Bian; Chuan Xu
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

Review 3.  An overview of signaling pathways regulating YAP/TAZ activity.

Authors:  Boon Chin Heng; Xuehui Zhang; Dominique Aubel; Yunyang Bai; Xiaochan Li; Yan Wei; Martin Fussenegger; Xuliang Deng
Journal:  Cell Mol Life Sci       Date:  2020-08-03       Impact factor: 9.261

4.  Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness.

Authors:  Hirofumi Omori; Kuniaki Sato; Takafumi Nakano; Takahiro Wakasaki; Satoshi Toh; Kenichi Taguchi; Takashi Nakagawa; Muneyuki Masuda
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-04       Impact factor: 4.553

5.  A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma.

Authors:  Shumei Song; Min Xie; Ailing W Scott; Jiankang Jin; Lang Ma; Xiaochuan Dong; Heath D Skinner; Randy L Johnson; Sheng Ding; Jaffer A Ajani
Journal:  Mol Cancer Ther       Date:  2017-11-22       Impact factor: 6.261

6.  A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.

Authors:  Katherine K Slemmons; Lisa E S Crose; Stefan Riedel; Manuela Sushnitha; Brian Belyea; Corinne M Linardic
Journal:  Mol Cancer Res       Date:  2017-09-18       Impact factor: 5.852

7.  PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression.

Authors:  Huan Liu; Xiaoming Dai; Xiaolei Cao; Huan Yan; Xinyan Ji; Haitao Zhang; Shuying Shen; Yuan Si; Hailong Zhang; Jianfeng Chen; Li Li; Jonathan C Zhao; Jindan Yu; Xin-Hua Feng; Bin Zhao
Journal:  EMBO Rep       Date:  2018-04-17       Impact factor: 8.807

8.  Role of YAP in lung cancer resistance to cisplatin.

Authors:  Juan Song; Li-Xia Xie; Xin-Yi Zhang; Ping Hu; Mei-Fang Long; Fang Xiong; Juan Huang; Xiao-Qun Ye
Journal:  Oncol Lett       Date:  2018-07-12       Impact factor: 2.967

Review 9.  The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.

Authors:  Xiao-Lan Liu; Rui Zuo; Wen-Bin Ou
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

Review 10.  Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

Authors:  Andrew P Feinberg; Michael A Koldobskiy; Anita Göndör
Journal:  Nat Rev Genet       Date:  2016-03-14       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.